Millipore Sigma Vibrant Logo

476475 PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated - Calbiochem

The PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated controls the biological activity of PKC. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: Myristoylated EGF-R Fragment (651-658), Protein Kinase C Inhibitor, Myr-N-RKRTLRRL-OH, Protein Kinase C Inhibitor, EGF-R Fragment 651-658, Myristoylated

Primary Target: PKC
View Products on Sigmaaldrich.com
476475
查看价格及供货情况

概述

Replacement Information

重要规格表

Empirical Formula
C₆₀H₁₁₇N₂₁O₁₁

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
476475-500UGCN
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 塑胶安瓿;塑胶针药瓶 500 μg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewEpidermal growth-factor receptor (EGF-R) conserved sequence which is identical to v-ErbB (95-102). An N-terminal myristoylated membrane-permeable, reversible, and substrate competitive inhibitor of protein kinase C (IC50 = 5 µM).
      Catalogue Number476475
      Brand Family Calbiochem®
      SynonymsMyristoylated EGF-R Fragment (651-658), Protein Kinase C Inhibitor, Myr-N-RKRTLRRL-OH, Protein Kinase C Inhibitor, EGF-R Fragment 651-658, Myristoylated
      References
      ReferencesWard, N.E., and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      O’Brian, C.A., et al. 1991. Invest. New Drugs 9, 169.
      Product Information
      ATP CompetitiveN
      FormLyophilized solid
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₆₀H₁₁₇N₂₁O₁₁
      Chemical formulaC₆₀H₁₁₇N₂₁O₁₁
      Hygroscopic Hygroscopic
      ReversibleY
      Sold on the basis of peptide contentY
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKC
      Primary Target IC<sub>50</sub>5 µM against protein kinase C
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide ContentY
      Peptide SequenceMyr-N-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Moisture Protect from moisture
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      476475-500UGCN 04055977183818

      Documentation

      PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated - Calbiochem 分析证书

      标题批号
      476475

      参考

      参考信息概述
      Ward, N.E., and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      O’Brian, C.A., et al. 1991. Invest. New Drugs 9, 169.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-January-2010 RFH
      SynonymsMyristoylated EGF-R Fragment (651-658), Protein Kinase C Inhibitor, Myr-N-RKRTLRRL-OH, Protein Kinase C Inhibitor, EGF-R Fragment 651-658, Myristoylated
      DescriptionEpidermal growth-factor receptor (EGF-R) conserved sequence which is identical to v-erbB (95-102). An N-terminal myristoylated membrane-permeable, reversible, and substrate competitive inhibitor that inhibits protein kinase C (IC50 = 5 µM) in intact cells.
      FormLyophilized solid
      FormulationSupplied as a trifluoroacetate salt.
      Chemical formulaC₆₀H₁₁₇N₂₁O₁₁
      Peptide SequenceMyr-N-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
      Purity≥97% by HPLC
      SolubilityH₂O (5 mg/ml)
      Storage Protect from moisture
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Toxicity Standard Handling
      ReferencesWard, N.E., and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      O’Brian, C.A., et al. 1991. Invest. New Drugs 9, 169.